New Treatment Allows Patient’s Immune System to Combat HIV

A study published in Cell Host & Microbe suggests that adding small molecules that imitate the T cell receptor CD4 to antiretroviral therapy could make latent HIV susceptible to the patient’s own antibodies.   Read More